Bone marrow production of erythrocytes can be increased by treatment with erythropoietin (EPO) in the weeks prior to surgery (consult EPO product literature for dosing details). Chronic use of EPO can be associated with thrombotic cardiovascular events, and caution is needed in vascular patients.